Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Goicoechea

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Medicine and Medical Research|January 24, 2012
Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up StudyEdward R Cachay, Michael R Peterson, Miguel Goicoechea, et al.
AIDS (London, England)|October 21, 2006
Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole useMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
AIDS Patient Care and Stds|April 21, 2006
Failure of modified directly observed therapy combined with therapeutic drug monitoring to enhance antiretroviral adherence in a patient with major depressionMiguel Goicoechea, Brookie Best, Edward Seefried, et al.
Antiviral Therapy|May 17, 2007
A computer-based system to aid in the interpretation of plasma concentrations of antiretrovirals for therapeutic drug monitoringMiguel Goicoechea, Andrea Vidal, Edmund Capparelli, et al.
Journal of Clinical Pharmacology|December 3, 2009
Interlaboratory measurement differences in intracellular carbovir triphosphate concentrations in HIV-infected patients: sources of variability in processing, shipping, and quantitationMiguel Goicoechea, Sonia Jain, Lucun Bi, et al.
The Journal of Infectious Diseases|June 3, 2006
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNAMiguel Goicoechea, Davey M Smith, Lin Liu, et al.
The Journal of Infectious Diseases|January 4, 2008
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapyMiguel Goicoechea, Shanshan Liu, Brookie Best, et al.
AIDS Research and Therapy|August 12, 2011
Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatmentEdward R Cachay, David L Wyles, Miguel Goicoechea, et al.
Viruses|January 25, 2025
Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat ResistanceHaydar Witwit, Beatrice Cubitt, Roaa Khafaji, et al.
AIDS (London, England)|January 21, 2010
Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patientsMiguel Goicoechea, Sonia Jain, Lucun Bi, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Medicine and Medical Research|January 24, 2012
Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up StudyEdward R Cachay, Michael R Peterson, Miguel Goicoechea, et al.
AIDS (London, England)|October 21, 2006
Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole useMiguel Goicoechea, Brookie Best, Edmund Capparelli, et al.
AIDS Patient Care and Stds|April 21, 2006
Failure of modified directly observed therapy combined with therapeutic drug monitoring to enhance antiretroviral adherence in a patient with major depressionMiguel Goicoechea, Brookie Best, Edward Seefried, et al.
Antiviral Therapy|May 17, 2007
A computer-based system to aid in the interpretation of plasma concentrations of antiretrovirals for therapeutic drug monitoringMiguel Goicoechea, Andrea Vidal, Edmund Capparelli, et al.
Journal of Clinical Pharmacology|December 3, 2009
Interlaboratory measurement differences in intracellular carbovir triphosphate concentrations in HIV-infected patients: sources of variability in processing, shipping, and quantitationMiguel Goicoechea, Sonia Jain, Lucun Bi, et al.
The Journal of Infectious Diseases|June 3, 2006
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNAMiguel Goicoechea, Davey M Smith, Lin Liu, et al.
The Journal of Infectious Diseases|January 4, 2008
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapyMiguel Goicoechea, Shanshan Liu, Brookie Best, et al.
AIDS Research and Therapy|August 12, 2011
Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatmentEdward R Cachay, David L Wyles, Miguel Goicoechea, et al.
Viruses|January 25, 2025
Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat ResistanceHaydar Witwit, Beatrice Cubitt, Roaa Khafaji, et al.
AIDS (London, England)|January 21, 2010
Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patientsMiguel Goicoechea, Sonia Jain, Lucun Bi, et al.
Pageof 3